Replies to post #246696 on Biotech Values

[DewDiligence]

IMGN sells 29.9M* shares @$12.50—a 2% premium to yesterday’s close:

https://finance.yahoo.com/news/immunogen-announces-pricing-upsized-public-234500092.html

Net proceeds after underwriting fees from this upsized offering will about $350M*.

*Assuming exercise of underwriter’s option.